Uyisenga, Jeanne P.
Debit, Ahmed
Poulet, Christophe
Frères, Pierre
Poncin, Aurélie
Thiry, Jérôme
Mutesa, Leon
Jerusalem, Guy
Bours, Vincent
Josse, Claire
Funding for this research was provided by:
Académie de recherche et d'enseignement supérieur (UR-ARES Project-R1)
Région Wallonne
Article History
Received: 26 January 2021
Accepted: 21 May 2021
First Online: 3 June 2021
Competing interests
: Dr. Jerusalem reports grants, personal fees and non-financial support from Novartis, grants, personal fees and non-financial support from Roche, grants, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Lilly, personal fees and non-financial support from Amgen, personal fees and non-financial support from BMS, personal fees and non-financial support from Astra-Zeneca, personal fees from Daiichi Sankyo, personal fees from Abbvie, non-financial support from Medimmune, non-financial support from MerckKGaA, outside the submitted work. Those funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. The other authors have no competing interests.